Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(17%)

Phase Distribution

Ph phase_4
1
17%
Ph phase_2
1
17%
Ph early_phase_1
1
17%
Ph not_applicable
3
50%

Phase Distribution

1

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)

Detailed Status

Completed3
Withdrawn1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 41 (16.7%)
N/A3 (50.0%)

Trials by Status

completed350%
withdrawn117%
not_yet_recruiting117%
terminated117%

Recent Activity

0 active trials
Showing 5 of 6
withdrawnearly_phase_1

Glucagon-like Peptide-1 in Type 1 Diabetes

NCT04355832
not_yet_recruitingphase_4

Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh

NCT06449235
completednot_applicable

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea

NCT03081676
terminatedphase_2

The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients

NCT00798590
completednot_applicable

Near Normalisation of BG Improves the Potentiating Effect of GLP-1

NCT00612625
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT04355832Early Phase 1

Glucagon-like Peptide-1 in Type 1 Diabetes

Withdrawn
NCT06449235Phase 4

Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh

Not Yet Recruiting
NCT03081676Not Applicable

The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea

Completed
NCT00798590Phase 2

The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients

Terminated
NCT00612625Not Applicable

Near Normalisation of BG Improves the Potentiating Effect of GLP-1

Completed
NCT00612950Not Applicable

Beta-Cell Function After Near-Normalisation of Blood Glucose

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6